- Home
- FTK vs CADL Comparison
FTK vs CADL Comparison
Compare FTK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- CADL
- Stock Information
- Founded
- FTK 1985
- CADL 1999
- Country
- FTK United States
- CADL United States
- Employees
- FTK N/A
- CADL N/A
- Industry
- FTK Major Chemicals
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- FTK Industrials
- CADL Health Care
- Exchange
- FTK Nasdaq
- CADL Nasdaq
- Market Cap
- FTK 212.1M
- CADL 234.8M
- IPO Year
- FTK N/A
- CADL 2021
- Fundamental
- Price
- FTK $15.64
- CADL $5.35
- Analyst Decision
- FTK Strong Buy
- CADL Strong Buy
- Analyst Count
- FTK 1
- CADL 4
- Target Price
- FTK $8.00
- CADL $21.00
- AVG Volume (30 Days)
- FTK 457.5K
- CADL 899.4K
- Earning Date
- FTK 05-06-2025
- CADL 05-13-2025
- Dividend Yield
- FTK N/A
- CADL N/A
- EPS Growth
- FTK 683.07
- CADL N/A
- EPS
- FTK 0.46
- CADL N/A
- Revenue
- FTK $202,013,000.00
- CADL N/A
- Revenue This Year
- FTK $9.41
- CADL N/A
- Revenue Next Year
- FTK $9.25
- CADL N/A
- P/E Ratio
- FTK $33.91
- CADL N/A
- Revenue Growth
- FTK 11.96
- CADL N/A
- 52 Week Low
- FTK $3.30
- CADL $3.79
- 52 Week High
- FTK $11.42
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- FTK 88.83
- CADL 51.97
- Support Level
- FTK $7.01
- CADL $5.03
- Resistance Level
- FTK $15.72
- CADL $5.59
- Average True Range (ATR)
- FTK 1.07
- CADL 0.36
- MACD
- FTK 0.87
- CADL 0.14
- Stochastic Oscillator
- FTK 96.76
- CADL 80.83
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.